Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Previous close
$207.00
Day range
$189.00 - $222.50
Year range
$43.60 - $277.00
Market cap
321.06B TWD
Avg Volume
27.73M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
In the news
Financials
Income Statement
Revenue
Net income
| (TWD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 12.21M | 55.61% |
Operating expense | 165.77M | -17.04% |
Net income | -248.81M | -40.85% |
Net profit margin | -2.04K | 9.48% |
Earnings per share | -0.16 | — |
EBITDA | -152.06M | 19.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.40B | 181.44% |
Total assets | 9.50B | 175.86% |
Total liabilities | 103.59M | 17.97% |
Total equity | 9.40B | — |
Shares outstanding | 1.55B | — |
Price to book | 34.16 | — |
Return on assets | -4.11% | — |
Return on capital | -4.15% | — |
Cash Flow
Net change in cash
| (TWD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -248.81M | -40.85% |
Cash from operations | -178.61M | 10.96% |
Cash from investing | -1.58B | -287.07% |
Cash from financing | 30.89M | 1,548.83% |
Net change in cash | -1.72B | -182.90% |
Free cash flow | -89.94M | 42.57% |
About
Founded
2012
Website
